Validation of the Diagnostic Utility of Mtb Protein Biomarkers Found in Urine of TB Patients

Antonio Campos-Neto of The Forsyth Institute in the U.S. along with collaborators Nira Pollock of The Beth Israel Deaconess Medical Center/Harvard Medical School and David Duffy of Quanterix Corporation, seek to validate seven M. tuberculosis proteins found in the urine of tuberculosis patients as biomarkers of active disease. The ultimate goal is to use the most promising markers to develop a non-invasive point-of-care test, which could be similar to a simple home-pregnancy test.